期刊文献+

siRNA沉默STAT3基因对人肝癌细胞的抑制及对相关生长调控基因的调节 被引量:6

Silencing of STAT3 expression by siRNA suppresses the growth of human hepatocellular carcinoma cellsand regulates genes related to growth control
下载PDF
导出
摘要 目的:探讨RNA干扰技术沉默STAT3基因表达对人肝癌细胞的抑制作用及对相关生长调控基因的调节.方法:构建pSilencer3.0-H1-siRNA-STAT3重组质粒,转染人肝癌细胞株SMMC 7721,采用MTT法观察重组质粒对肝癌细胞的生长抑制,RT-PCR和Western blot及免疫组化法分别观察STAT3基因和蛋白水平的变化,同时检测survivin,c-myc,VEGF,p53,caspase3生长调控基因的mRNA,并用流式细胞技术(FCM)及AO/EB染色方法观察细胞凋亡.结果:pSilencer 3.0-H1-siRNA-STAT3重组质粒对肝癌细胞的生长有抑制作用,实验组48h和72h抑制率分别为59.32%,76.49%,与空白组及阴性组细胞相比有显著性差异(P<0.01);在重组质粒组,STAT3基因mRNA及蛋白水平表达降低,surviving,VEGF的mRNA表达下调,p53,caspase3的mRNA表达上调(P<0.01),c-myc的mRNA表达却无明显改变;重组质粒可诱导SMMC 7721细胞凋亡,凋亡率达21.6%(P<0.01),细胞周期分析显示细胞阻滞于G2期.结论:pSilencer3.0-H1-STAT3-siRNA可能通过下调基因survivin和VEGF mRNA表达,上调p53和caspase3 mRNA表达来抑制STAT3基因在人肝癌细胞中的表达. AIM: To explore the effect of silencing STAT3 expression by siRNA on the growth of human hepatocellular carcinoma cells and the regulation of genes related to growth control. METHODS: We reconstructed the recombinant plasmid of pSilencer 3.0-H1-STAT3-siRNA-GFP, which was then transfected into SMMC 7721 cells. MTT assay was applied to investigate the proliferation of transfected SMMC 7721 cells, and the protein expression level of STAT3 was determined by Western blotting and immunohistochemical staining. The transcription of the STAT3 gene was detected by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR), mRNA expression for growth-controlrelated genes such as survivin, c-myc, VEGF, p53 and caspase3 was detected in transfected cells at the same time. Flow cytometry (FCM) and AO/ EB double staining were used to observe apoptosis in transfected cells. RESULTS: MTT assay demonstrated that cell growth was inhibited in transfected cells, and the 48-hour and 72-hour inhibition rates of the test group were 59.32 and 76.49%, respectively. There were significant differences compared to those of the mock-treated and negative groups (P 〈 0.01). The results of RT-PCR and Western blotting showed that mRNA and protein levels of STAT3 declined markedly in transfected cells. Genes related to growth control also changed at the mRNA level, and expression of survivin and VEGF in transfected cells was obviously reduced. The expression of p53 and caspase3 in transfected cells increased. The ratios of the above expression products in the test group were significantly different compared to those of the negative and mock-treated groups, while the expression of c-myc in transfected cells did not change. The results of FCM and AO/EB double staining indicated that there was apparent cell apoptosis in the test group; the apoptosis rate was 21.6% (P 〈 0.01). There were significant dif- ferences compared to those of the mock-treated and negative groups. Analysis of the cell cycle showed that cells were inhibited in the G2 stage. CONCLUSION: The recombinant plasmid of pSilencer 3.0-H1-STAT3-siRNA-GFP can significantly inhibit the expression of the STAT3 gene in SMMC 7721 cells. The mechanism may be related to the down-regulation of survivin and VEGF mRNA expression and the up-regulation of p53 and caspase3 mRNA expression.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第19期2101-2107,共7页 World Chinese Journal of Digestology
关键词 STAT3基因 肝癌 RNA干涉 pSilencer 3.0-H1-siRNA-STAT3重组质粒 细胞凋亡 STAT3 gene, Hepatocellular carcinoma,RNA interference pSilencer recombinant plasmidof 3.0-H1-STAT3-siRNA-GFP Apoptosis
  • 相关文献

参考文献7

二级参考文献61

  • 1Yan Li Zhao-You Tang Sheng-Long Ye Yin-Kun Liu Jie Chen Qiong Xue Jun Chen Dong-Mei Gao Wei-Hua Bao Liver Cancer Institute and Zhongshan Hospital of Fudan University (Former Liver Cancer Institute of Shanghai Medical University),Shanghai 200032,China.Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97[J].World Journal of Gastroenterology,2001,7(5):630-636. 被引量:112
  • 2Akiyama M, Yamada O, Yamada H,et al. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett, 2002,178:187-197.
  • 3Sui G, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc.Natl Acad Sci U S A, 2002, 99:5515-5520.
  • 4Zou Lin, Luo CL, Tu ZG, et al. Expression of hTERT and c-myc mRNA in transitional cell carcinoma of the bladder (TCCB). Chinese Med J, 2002, 16: 103-106.
  • 5Wilda M, Fuchs U, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene, 2002, 21:5716-5724.
  • 6Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature, 2002, 418:435-438.
  • 7Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression replication by RNA interference. Hepatology, 2003, 37:764-770.
  • 8Sharookh BK, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci U S A, 2003,100: 2014-2018.
  • 9Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs.Genes Dev, 2001, 15:188-200.
  • 10Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma. Nat Med, 1997, 3(8): 917 -921

共引文献124

同被引文献128

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部